Prairiewood Capital’s Medifast MED Stock Holding History

Prairiewood Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,215	Closed	-$276K	–	83
2024 Q1	$276K	Buy	7,215 +1,520	+27%	+$73.6K	0.13%	69
2023 Q4	$383K	Buy	5,695 +2	+0%	+$139	0.2%	65
2023 Q3	$426K	Buy	5,693 +62	+1%	+$5.5K	0.28%	57
2023 Q2	$519K	Buy	5,631 +1,134	+25%	+$101K	0.35%	51
2023 Q1	$466K	Buy	4,497 +726	+19%	+$80.5K	0.32%	54
2022 Q4	$435K	Buy	3,771 +2	+0.1%	+$233	0.32%	54
2022 Q3	$408K	Buy	3,769 +838	+29%	+$120K	0.34%	56
2022 Q2	$529K	Hold	2,931	–	–	0.42%	44
2022 Q1	$501K	Buy	2,931 +1,841	+169%	+$347K	0.35%	50
2021 Q4	$228K	Hold	1,090	–	–	0.18%	67
2021 Q3	$210K	Hold	1,090	–	–	0.17%	67
2021 Q2	$308K	Sell	1,090 -3,372	-76%	-$914K	0.26%	61
2021 Q1	$945K	Hold	4,462	–	–	0.87%	36
2020 Q4	$876K	Buy	+4,462	New	+$789K	0.89%	34

Other funds holding MED

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Hotchkis & Wiley Capital Management

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return